Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
0.5281
-0.0885 (-14.35%)
At close: Nov 13, 2026, 4:00 PM EST
0.5349
+0.0068 (1.29%)
After-hours: Nov 13, 2026, 6:16 PM EST
CELZ Revenue
Creative Medical Technology Holdings had revenue of $3.00K in the twelve months ending September 30, 2026, down -50.00% year-over-year. In the year 2025, Creative Medical Technology Holdings had annual revenue of $6.00K, down -45.45%. That makes Creative Medical Technology Holdings the 47,527th largest company in the world by revenue and 7,246th in the United States.
Revenue (ttm)
$3.00K
Revenue Growth
-50.00%
P/S Ratio
1,160.51
Revenue / Employee
$750
Employees
4
Market Cap
3.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.00K | -5.00K | -45.45% |
| Dec 31, 2024 | 11.00K | 2.00K | 22.22% |
| Dec 31, 2023 | 9.00K | -79.60K | -89.84% |
| Dec 31, 2022 | 88.60K | 846.00 | 0.96% |
| Dec 31, 2021 | 87.75K | -76.75K | -46.65% |
| Dec 31, 2020 | 164.50K | -1.00K | -0.60% |
| Dec 31, 2019 | 165.50K | 41.10K | 33.04% |
| Dec 31, 2018 | 124.40K | 119.60K | 2,491.67% |
| Dec 31, 2017 | 4.80K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
CELZ News
- 24 days ago - Creative Medical provides additional clinical, laboratory findings for Ultrasome - TheFly
- 24 days ago - Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study - GlobeNewsWire
- 1 month ago - Creative Medical files new U.S. provisional patent application for Ultrasome - TheFly
- 1 month ago - Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing - GlobeNewsWire
- 2 months ago - Roth believes Creative Medical’s ADAPT trial in CLBO ‘likely to succeed’ - TheFly
- 2 months ago - Creative Medical completes enrollment in ADAPT clinical trial - TheFly
- 2 months ago - Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning - GlobeNewsWire
- 3 months ago - Creative Medical receives notice of allowance for new U.S. patent - TheFly